Current Hypertension Reports

, Volume 1, Issue 2, pp 127–130 | Cite as

Obesity and cardiovascular hemodynamic function

  • Rainer Koch
  • Arya M. Sharma
Article

Abstract

Marked abnormalities in cardiovascular structure and hemodynamic function are present both in normotensive and hypertensive obese individuals. Cardiac abnormalities include excentric left ventricular hypertrophy and left atrial dilatation, a finding compatible with the presence of cardiac volume overload. In contrast, hypertension, often associated with abdominal obesity, is characterized by increased peripheral resistance and concentric hypertrophy. Weight reduction can result in marked improvement of ventricular dimensions and cardiac function in patients undergoing massive weight reduction following bariatric surgery. In this paper we review recent findings that have broadened our understanding of cardiovascular hemodynamic function in obesity.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References and Recommended Reading

  1. 1.
    Kortelainen ML: Association between cardiac pathology and fat tissue distribution in an autopsy series of men without premortem evidence of cardiovascular disease. Int J Obes Relat Metab Disord 1996, 20:245–252.PubMedGoogle Scholar
  2. 2.
    de Simone G, Devereux RB, Roman MJ, et al.: Relation of obesity and gender to left ventricular hypertrophy in normotensive and hypertensive adults. Hypertension 1994, 23:600–606.PubMedGoogle Scholar
  3. 3.
    Gottdiener JS, Reda DJ, Williams DW, Materson BJ: Left atrial size in hypertensive men: influence of obesity, race and age. Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents. J Am Coll Cardiol 1997, 29:651–658. To our knowledge this is the first study that highlights left atrial size as an important structural aspect in obesity.PubMedCrossRefGoogle Scholar
  4. 4.
    Connolly HM, Crary JL, McGoon MD, et al.: Valvular heart disease associated with fenfluramine-phentermine. N Engl J Med 1997, 337:581–588.PubMedCrossRefGoogle Scholar
  5. 5.
    Khan MA, Herzog CA, St. Peter JV, et al.: The prevalence of cardiac valvular insufficiency assessed by transthoracic echocardiography in obese patients treated with appetite-suppressant drug. N Engl J Med 1998, 339:713–718.PubMedCrossRefGoogle Scholar
  6. 6.
    Jick H, Vasilakis C, Weinrauch LA, et al.: A population-based study of appetite-suppressant drugs and the risk of cardiacvalve regurgitatio. N Engl J Med 1998, 339:719–724.PubMedCrossRefGoogle Scholar
  7. 7.
    Weissman NJ, Tighe JF, Jr., Gottdiener JS, Gwynne JT: An assessment of heart-valve abnormalities in obese patients taking dexfenfluramine, sustained-release dexfenfluramine, or placebo. Sustained-Release Dexfenfluramine Study Group. N Engl J Med 1998, 339:725–732.PubMedCrossRefGoogle Scholar
  8. 8.
    Paulson DJ, Tahiliani AG: Cardiovascular abnormalities associated with human and rodent obesity. Life Sci 1992, 51:1557–1569.PubMedCrossRefGoogle Scholar
  9. 9.
    de Simone G, Devereux RB, Daniels SR, et al.: Stroke volume and cardiac output in normotensive children and adults. Assessment of relations with body size and impact of overweight. Circulation 1997, 95:1837–1843. This article identifies the relationship of stroke volume and cardiac output to allometric measures of body size in subjects across a broad range of ages.PubMedGoogle Scholar
  10. 10.
    Devereux RB, Roman MJ, Paranicas M, et al.: Relations of Doppler stroke volume and its components to left ventricular stroke volume in normotensive and hypertensive American Indians: the Strong Heart Study. Am J Hypertens 1997, 10:619–628.PubMedCrossRefGoogle Scholar
  11. 11.
    Crandall DL, Hausman GJ, Kral JG: A review of the microcirculation of adipose tissue: anatomic, metabolic, and angiogenic perspectives. Microcirculation 1997, 4:211–232.PubMedCrossRefGoogle Scholar
  12. 12.
    Crandall DL, Gordon G, Herzlinger HE, et al.: Transforming growth factor alpha and atrial natriuretic peptide in white adipose tissue depots in rats. Eur J Clin Invest 1992, 22:676–680.PubMedGoogle Scholar
  13. 13.
    Frederich RC Jr, Kahn BB, Peach MJ, Flier JS: Tissue-specific nutritional regulation of angiotensinogen in adipose tissue. Hypertension 1992, 19:339–344.PubMedGoogle Scholar
  14. 14.
    Jones BH, Standridge MK, Taylor JW, Moustaid N: Angiotensinogen gene expression in adipose tissue: analysis of obese models and hormonal and nutritional control. Am J Physiol 1997, 273:R236–242.PubMedGoogle Scholar
  15. 15.
    Daniels SR, Kimball TR, Khoury P, et al.: Correlates of the hemodynamic determinants of blood pressure. Hypertension 1996, 28:37–41.PubMedGoogle Scholar
  16. 16.
    Crandall DL, DiGirolamo M: Hemodynamic and metabolic correlates in adipose tissue: pathophysiologic considerations. FASEB J 1990, 4:141—147.PubMedGoogle Scholar
  17. 17.
    Segal KR, Lacayanga I, Dunaif A, et al.: Impact of body fat mass and percent fat on metabolic rate and thermogenesis in men. Am J Physiol 1989, 256:573–579.Google Scholar
  18. 18.
    Mureddu GF, de Simone G, Greco R, et al.: Left ventricular filling in arterial hypertension. Influence of obesity and hemodynamic and structural confounders. Hypertension 1997, 29:544–550.PubMedGoogle Scholar
  19. 19.
    Jern S, Bergbrant A, Bjorntorp P, Hansson L: Relation of central hemodynamics to obesity and body fat distribution. Hypertension 1992, 19:520–527.PubMedGoogle Scholar
  20. 20.
    Vetta F, Cicconetti P, Ronzoni S, et al.: Hyperinsulinaemia, regional adipose tissue distribution and left ventricular mass in normotensive, elderly, obese subjects. Eur Heart J 1998, 19:326–331.PubMedCrossRefGoogle Scholar
  21. 21.
    Laaban JP, Cassuto D, Orvoen-Frija E, et al.: Cardiorespiratory consequences of sleep apnoea syndrome in patients with massive obesity. Eur Respir J 1998, 11:20–27.PubMedCrossRefGoogle Scholar
  22. 22.
    Alpert MA, Terry BE, Mulekar M, et al.: Cardiac morphology and left ventricular function in normotensive morbidly obese patients with and without congestive heart failure, and effect of weight loss. Am J Cardiol 1997, 80:736–740. This study compares indices of cardiac morphology and LV function and assesses the effect of weight loss on these variables in morbidly obese patients with and without congestive heart failure.PubMedCrossRefGoogle Scholar
  23. 23.
    Gahtan V, Goode SE, Kurto HZ, et al.: Body composition and source of weight loss after bariatric surger. Obes Surg 1997, 7:184–188.PubMedCrossRefGoogle Scholar

Copyright information

© Current Science Inc 1999

Authors and Affiliations

  • Rainer Koch
    • 1
  • Arya M. Sharma
    • 1
  1. 1.Medizinische Klinik, Klinkum Benjamin FranklinFree University of BerlinBerlinGermany

Personalised recommendations